| Financial Year |
March 31 2023 |
| Monetary Funds |
195,855,280,000.00 |
| Held-for-trading Financial Assets |
10,720,718,000.00 |
| Notes Receivable |
2,961,499,000.00 |
| Accounts Receivable |
148,202,753,000.00 |
| Advances to Suppliers |
49,165,382,000.00 |
| Other Receivables |
38,831,151,000.00 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
1,524,774,000.00 |
| Dividend Receivable |
146,217,000.00 |
| Inventories |
225,003,967,000.00 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
13,322,396,000.00 |
| Other Current Assets |
55,484,055,000.00 |
| Total Current Assets |
917,317,124,000.00 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
19,565,270,000.00 |
| Long-term Equity Investment |
112,393,870,000.00 |
| Investment Properties |
15,439,600,000.00 |
| Fixed Assetes |
66,989,954,000.00 |
| Under-construction Projects |
52,111,185,000.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
176,097,603,000.00 |
| R&D expenses |
253,491,000.00 |
| Goodwill |
1,789,189,000.00 |
| Long-Term Deferred and Prepaid Expenses |
1,213,591,000.00 |
| Deferred Income Tax Assets |
12,111,641,000.00 |
| Other Non-Current Assets |
229,849,731,000.00 |
| Sub-Total of Non-Current Assets |
738,745,479,000.00 |
| Total Assets |
1,656,062,603,000.00 |
| Short-Term Loans |
81,260,222,000.00 |
| Trading Financial liabilities |
52,976,000.00 |
| Notes Payable |
90,309,173,000.00 |
| Accounts Payable |
391,340,694,000.00 |
| Accounts Received In Advance |
1,042,239,000.00 |
| Employee Compensation Payable |
3,765,742,000.00 |
| Taxes Payable |
13,414,758,000.00 |
| Interest Payable |
511,488,000.00 |
| Dividend Payable |
203,057,000.00 |
| Other payables |
82,234,129,000.00 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
35,633,900,000.00 |
| Other Current Liabilities |
33,562,251,000.00 |
| Sub-Total of Current Liabilities |
886,054,926,000.00 |
| Long-term Loans |
260,083,363,000.00 |
| Bonds Payable |
38,271,629,000.00 |
| Long-Term Accounts Payable |
28,490,056,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
604,372,000.00 |
| Deferred Income Tax Liabilities |
2,898,779,000.00 |
| Other Non-Current Liabilities |
33,446,000.00 |
| Sub-Total of Non-Current Liabilities |
334,655,356,000.00 |
| Total Liabilities |
1,220,710,282,000.00 |
| Paid-In Capital(Or Share Stock) |
24,752,196,000.00 |
| Capital Surplus |
56,479,602,000.00 |
| Surplus Reserve |
15,862,377,000.00 |
| LESS:Treasury Stock |
611,855,000.00 |
| Undistributed Profits |
163,086,680,000.00 |
| Minority Stockholder's Interest |
126,613,239,000.00 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
308,739,082,000.00 |
| Owner's Equity（Stockholder's Equity） |
435,352,321,000.00 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,656,062,603,000.00 |
